Evidence-Based Practice Recommendations
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
According to the American Academy of Allergy, Asthma, and Immunology, patients with allergic asthma whose symptoms are not well controlled by medications or avoidance measures or who require high medication doses, multiple medications, or both to maintain control of their allergic disease might be good candidates for immunotherapy.
(https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Allergen-immunotherapy-Jan-2011.pdf Last Accessed: October 22, 2021)Strength of Recommendation: Expert Opinion/Consensus Statement
In adult and adolescent patients with severe asthma being considered for omalizumab, the American Thoracic Society and the European Respiratory Society recommend using a blood eosinophil cut-off ≥260 mcL to identify those with severe allergic asthma more likely to benefit from anti-IgE treatment.
(https://erj.ersjournals.com/content/55/1/1900588 Last Accessed: October 22, 2021)Strength of Recommendation/Level of Evidence: Conditional recommendation, low quality of evidence
According to the American College of Obstetricians and Gynecologists, the ultimate goal of asthma therapy in pregnancy is maintaining adequate oxygenation of the fetus by preventing hypoxic episodes in the mother.
(https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2008/02/asthma-in-pregnancy Last Accessed: October 22, 2021)Level of Evidence: B (Limited or inconsistent scientific evidence)
The British Occupational Health Research Foundation recommends that healthcare providers provide more frequent health surveillance to workers who develop rhinitis when working with agents known to cause occupational asthma and ensure that the workplace and working practices are investigated to identify potential causes and implement corrective actions.
(https://www.bohrf.org.uk/downs/OccupationalAsthmaEvidenceReview-Mar2010.pdf Last Accessed: October 22, 2021)Level of Evidence: ** (One study with high quality and at least two studies with medium quality)
The American College of Asthma, Allergy, and Immunology recommends nonpharmacologic therapy to prevent and partially reduce the severity of exercise-induced asthma, specifically pre-exercise warm-up.
(https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/Exercise-Induced-Bronchoconstriction-Practice-Parameter-2016.pdf Last Accessed: October 22, 2021)Strength of Recommendation: A (Strong recommendation)
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.